Ocular Therapeutix (OCUL) EBITDA (2013 - 2026)
Ocular Therapeutix (OCUL) reported EBITDA of -$79.62 million for Q2 2026, compared with -$65.91 million a year earlier.
Powered by 
Analysis
Ocular Therapeutix (OCUL) EBITDA (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ocular Therapeutix's EBITDA came in at -$305.18 million; for FY2025, it was -$262.3 million.
- By year, EBITDA came in at -$164.26 million in FY2024, -$73.29 million in FY2023, -$71.69 million in FY2022 and -$70.99 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$90.68 million in Q1 2026 and a high of -$16.09 million in Q1 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$90.68 million (Q1 2026), -$68.02 million (Q4 2025) and -$66.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Ocular Therapeutix | 1.51 Bn | -833.26 Mn | 11.46 Mn | -79.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.62 Mn |
| Mar 31, 2026 | -90.68 Mn |
| Dec 31, 2025 | -68.02 Mn |
| Sep 30, 2025 | -66.87 Mn |
| Jun 30, 2025 | -65.91 Mn |
| Mar 31, 2025 | -61.50 Mn |
| Dec 31, 2024 | -49.05 Mn |
| Sep 30, 2024 | -44.42 Mn |
| Jun 30, 2024 | -42.07 Mn |
| Mar 31, 2024 | -28.73 Mn |
| Dec 31, 2023 | -17.54 Mn |
| Sep 30, 2023 | -16.25 Mn |
| Jun 30, 2023 | -18.67 Mn |
| Mar 31, 2023 | -20.84 Mn |
| Dec 31, 2022 | -17.63 Mn |
| Sep 30, 2022 | -19.81 Mn |
| Jun 30, 2022 | -18.16 Mn |
| Mar 31, 2022 | -16.09 Mn |
| Dec 31, 2021 | -16.29 Mn |
| Sep 30, 2021 | -17.78 Mn |
API Access
Ocular Therapeutix EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();